The fast rise of artificial intelligence (AI) in healthcare, along with more money coming from private equity, is changing the industry quickly. From AI-assisted tools that help diagnose illnesses to systems that keep an eye on patients without human input, these technologies offer better efficiency and can grow with demand. But as private companies use AI to cut costs and improve processes, there are worries about the effects on patient care and safety.
Key Takeaways
The integration of artificial intelligence (AI) in healthcare by private equity firms raises concerns about patient care and safety.
- Private equity-backed hospitals have seen a drop in patient satisfaction after being acquired, with ratings falling by 5.2% and patients willing to recommend them dropping by 4.4% within three years.
- AI systems can make mistakes, such as creating ‘hallucinations’ that lead to wrong information or treatments, which can be dangerous in healthcare.
- Human oversight remains crucial when using AI in healthcare, as AI limitations need careful management to protect patient care and safety.
Private equity’s push into healthcare and AI
Private equity firms are making big moves into healthcare, buying up hospitals and medical practices. They usually focus on boosting their investments by reorganizing operations and cutting costs. While this approach can make a business more profitable, it also raises concerns about how it affects patient care.
$ORCL Ellison sees AI transforming healthcare — here’s how 👇
• $TEM — Platform Powering Precision Medicine
• $PSNL – Decoding Genomes
• $RXRX — AI-Driven Drug Discovery
• $SDGR — AI-Driven Drug Design
• $ABCL — The AI Hunter for Antibodiespic.twitter.com/SiiT3esdVm— Shay Boloor (@StockSavvyShay) January 23, 2025
A study in JAMA shows the real impact of private equity takeovers on patient care experiences. Hospitals that were bought by these firms from 2010 to 2017 saw a drop in patient satisfaction. Ratings for these hospitals fell by 5.2%, and the number of patients willing to recommend them dropped by 4.4% within three years. These declines were seen in areas like staff response, communication, and the hospital environment.
This has sparked questions about whether making money should be the main focus when healthcare is supposed to prioritize patient care. Using AI in these situations could make things worse if not properly controlled. AI tools, such as transcription systems and diagnostic platforms, are meant to make work more efficient, but they might end up focusing more on saving time and money rather than improving patient outcomes.
The dual-edged sword of AI in healthcare
AI technologies offer undeniable potential to enhance healthcare delivery. From transcription tools like OpenAI’s Whisper to AI nurses developed by companies like Hippocratic AI, these systems promise to revolutionize workflows, reduce administrative burdens, and improve access to care. However, as private institutions adopt AI, the risks associated with its deployment become more pronounced.
Flaws in AI systems
AI systems, even with their advanced technology, can still make mistakes. In healthcare, these mistakes can be quite serious. For instance, OpenAI’s Whisper, a tool that helps transcribe spoken words into text, sometimes creates “hallucinations.” This means it might invent medical details or give wrong information, which can be very dangerous in healthcare.
Imagine a made-up medicine name in a patient record; it could lead to wrong treatments or even put lives at risk. These errors hurt not only the usefulness of AI but also the trust patients and doctors have in these systems.
Dr. Niusha Shafiabady, who knows a lot about smart computing, warns about the risks of AI making decisions on its own in healthcare. These systems handle lots of data and make choices without human help, which can be risky. In healthcare, each patient is unique, and AI may not understand these small but important differences. So, an AI could make decisions that seem right to a computer but are not safe or best for the patient.
For example, an AI watching over a patient’s vitals might focus only on keeping numbers normal. If a patient’s blood pressure changes, it might give unnecessary medicine, causing unwanted side effects. Dr. Shafiabady highlights that even top-notch AI models can fail in unexpected situations they weren’t built for. A system might work perfectly in the lab but not so well in real-life, unpredictable scenarios, showing the complexity of autonomous AI.
These issues show why human oversight remains crucial when using AI in healthcare. While AI can make things faster and handle loads of data, its limitations need careful management to protect patient care and safety.
Profit-driven AI deployment
Private equity-backed healthcare providers may find AI particularly attractive for its potential to reduce costs. AI-powered nurses, such as those offered by Hippocratic AI for $9 per hour compared to $90 per hour for human practitioners, illustrate how institutions might prioritize financial savings.
However, these systems may lack the nuanced judgment of human caregivers, potentially leading to aggressive or inappropriate interventions. For instance, an AI system managing patient vitals might overmedicate in response to abnormal readings, disregarding critical contextual factors that are difficult to program.
Implications for patient care
The integration of flawed or insufficiently tested AI tools into private equity-acquired facilities could further deteriorate patient experiences, compounding the negative trends observed in post-acquisition satisfaction studies. As private institutions seek to maximize profits, they may be less inclined to invest in the refinement of AI systems or the robust oversight needed to mitigate risks. This misalignment between profit motives and patient welfare underscores the ethical challenges at the heart of AI deployment in healthcare.
Balancing innovation with ethical responsibility
The intersection of private investment and AI in healthcare demands a comprehensive framework to ensure that technological advancements benefit patients without compromising safety or equity. Policymakers, developers, and healthcare providers must work collaboratively to address these challenges and uphold ethical standards.
1. Enhancing transparency and accountability
Transparency is crucial for fostering trust in AI systems and private healthcare providers. Policymakers should mandate detailed disclosures about private equity transactions, AI applications, and the performance of these systems in clinical settings. Regular audits and public reporting can help hold institutions accountable and ensure that patient care remains a priority.
2. Refining AI systems
AI developers must prioritize reducing errors and improving reliability. Addressing issues like hallucinations in transcription tools is critical to maintaining the integrity of medical records and ensuring accurate communication between providers and patients. Additionally, AI systems must be designed to account for the complexities and uncertainties inherent in healthcare environments, reducing the risk of harmful interventions.
3. Safeguarding patient privacy
The use of AI in healthcare often requires extensive patient data, raising significant privacy concerns. Clear consent protocols and stringent data protection measures are essential to prevent misuse and build trust. For example, sharing consultation audio with third-party vendors, as some institutions have proposed, should be subject to robust oversight to ensure compliance with ethical and legal standards.
4. Promoting ethical AI deployment
Private institutions must align their AI deployment strategies with the principles of patient-centered care. This includes investing in training and education for healthcare professionals to ensure they can effectively oversee and complement AI systems. Interdisciplinary collaboration among ethicists, technologists, clinicians, and patient advocates can help design AI applications that balance innovation with ethical responsibility.
5. Implementing regulatory guardrails
Governments and regulatory bodies must establish clear guidelines for AI use in healthcare, particularly in high-risk domains. For instance, Australia has introduced specific guardrails for AI deployment in health settings to mitigate risks associated with autonomous systems. Similar initiatives globally could help ensure that AI serves as a tool for enhancing care rather than a source of harm.
Final thoughts
When private equity invests in AI for healthcare, it creates both chances and challenges. AI can greatly improve how we care for patients, but using it in profit-focused healthcare systems can lead to ethical issues. It’s vital that the focus on being efficient and making money doesn’t compromise safety, fairness, or the main goals of patient care.
As more private companies use AI, it’s crucial for policymakers and healthcare leaders to ensure transparency, accountability, and ethical practices. By striking a balance that puts patient well-being first, we can use AI’s power for good while protecting the fairness and honesty of healthcare systems. In this fast-changing world, careful regulation is needed to make sure that innovation builds trust and improves care, rather than weakening it.